Korean study checks soliris safety in everyday use for rare nerve disease
NCT ID NCT06448715
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study looked at 11 Korean adults with a rare nerve disease called NMOSD who were already taking or starting the drug Soliris. Researchers tracked side effects and how well the drug prevented relapses in normal medical practice. The goal was to confirm the drug's safety and effectiveness outside of controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSERVATIONAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Goyang-si, South Korea
-
Research Site
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.